A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke

Conditions: Chronic Ischemic Stroke Interventions: Drug: hNPC01 Sponsors: Hopstem Biotechnology Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials